Medrx reported the monthly exercise status of the 35th Stock Acquisition Rights issued through a third-party allotment, with an exercise price adjustment provision, in a timely disclosure. The disclosure outlines the background to the issuance of the rights and the actual exercise activity during the month.
Medrx reported the issuance of the 35th Stock Acquisition Rights through a third-party allotment. The rights include an exercise price adjustment provision.
This report compiles and discloses the monthly exercise status of the stock acquisition rights and was presented as a timely disclosure dated 2 November 2026.
The report focuses on the purpose of the issuance and the monthly exercise results, conveying the developments during the month to readers.